RBM Board Meeting agrees changes to capitalise on the gains made to date and to respond to new directions for development
The Global Fund partnership has launched a consultation as part of a process to engage a wide range of stakeholders in developing its 2017-2021 strategy
World Health Organization (WHO) is calling on the global health community to urgently address significant gaps in the prevention, diagnosis and treatment of malaria. Despite dramatic declines in malaria cases and deaths since 2000, more than half a million lives are still lost to this preventable disease each year
To mark World Malaria Day, the ACT Consortium hosted the symposium “Invest in the future: defeat malaria” on 23 April 2015 at the London School of Hygiene & Tropical Medicine.
A rigorous analysis of antimalarial drug quality conducted in Cambodia and Tanzania found no evidence of fake medicines, according to new research published in the American Journal of Tropical Medicine and Hygiene. Researchers welcome reassuring findings but note poor quality drugs are still a problem.
Os investigadores recebem com agrado estas conclusões tranquilizadoras, mas indicam que os medicamentos de qualidade reduzida continuam a constituir um problema.
Les chercheurs se réjouissent des résultats rassurants mais font remarquer que les médicaments de mauvaise qualité demeurent un problème.
The ACT Consortium will host a drug quality meeting entitled "Fake antimalarials: start with the facts" on 28th May 2015 in Geneva, Switzerland. Deadline to RSVP is 8 May.
The appearance of artemisinin-resistant Plasmodium falciparum malaria in the Greater Mekong sub-region is a major threat to global health security, and would have a significant economic impact that may seriously undermine years of malaria investment, says Dr Tim France from the Asia Pacific Leaders Malaria Alliance in “The Roll Back Malaria (RBM) Partnership World Malaria Day blog series”.
Read the latest Roll Back Malaria (RBM) partnership World Malaria Day blog by Elisabeth Wilhelm from MACEPA and Global Health Corps
To mark World Malaria Day, the ACT Consortium is convening a group of experts to discuss important aspects of malaria control.
Date: Thursday 23 April 2015
Time: 5:30 pm - 7:00 pm BST
Venue: John Snow Lecture Theatre, LSHTM, Keppel Street, London, WC1E 7HT, UK
The Malawi National Malaria Control Programme launched the results of the 2014 Malawi Malaria Indicator Survey (MIS) during the 2015 malaria research dissemination day in Lilongwe, an event attended by a wide range of health professionals and journalists.
Delegates debated policy implications for the use of malaria rapid diagnostic tests (RDTs) in the public and private health sectors. ACT Consortium members presented research results at the annual retreat of the Malaria Centre from the London School of Hygiene & Tropical Medicine in Cambridge, UK.
After months of extensive and worldwide consultation in all sectors of society, a public review of the penultimate version of the GMAP2 - "Towards a Malaria Free-World: A Global Case for Investment and Action 2016-2030" - is open until 28 March.
Resistance to the antimalarial drug artemisinin is established in Myanmar and has reached within 25km of the Indian border, a study published today in The Lancet Infectious Diseases reports. Artemisinin resistance threatens to follow the same historical trajectory from Southeast Asia to the Indian subcontinent as seen in the past with other antimalarial medicines.
« previous 1 2 3 4 5 6 7 8 9 next »
View current news